Sankala Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Sankala Group's BTAL Position: Q2 2026 in Review
Sankala Group increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 251% in Q2 2026, buying an estimated $150K and bringing the position to 17,211 shares worth $209K. The position accounts for 0.14% of the portfolio, ranked #140.
Sankala Group first reported a position in BTAL in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Sankala Group held 17,211 shares of AGF US Market Neutral Anti-Beta Fund worth $209K as of Q2 2026.
- Sankala Group bought 12,314 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $150K.
- AGF US Market Neutral Anti-Beta Fund made up 0.14% of Sankala Group's portfolio in Q2 2026, its #140 holding.
- Sankala Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 3 quarters since.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.